Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.360
+0.180 (5.66%)
Jul 27, 2026, 3:16 PM EDT - Market open
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $1.01 billion as of July 27, 2026. Its market cap has decreased by -9.75% in one year.
Market Cap
1.01B
Enterprise Value
968.16M
1-Year Change
-9.75%
Ranking
Category
Stock Price
$3.36
ChartMarket Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $1.01B, a decrease of -23.95%. That is a compound annual growth rate of -4.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 1.01B | -7.05% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 1.02B |
| Olema Pharmaceuticals | 1.02B |
| Lexicon Pharmaceuticals | 1.02B |
| LB Pharmaceuticals | 1.00B |
| Avalo Therapeutics | 975.53M |
| Janux Therapeutics | 934.89M |
| Kura Oncology | 922.37M |
| Geron | 910.96M |